Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Recurrent Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06465069
What this trial is testing

LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 420
Early research (Phase 1)Looking for participantsNCT07030907
What this trial is testing

Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer
Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT02055690
What this trial is testing

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsNeoplasms, OvarianOvarian Cancer
The Christie NHS Foundation Trust 21
Early research (Phase 1)Study completedNCT00357448
What this trial is testing

Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+8 more
University of Washington 11
Testing effectiveness (Phase 2)Ended earlyNCT06257758
What this trial is testing

VIO-01 in Participants With Recurrent Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerRecurrent Ovarian Cancer+1 more
Valerio Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00278343
What this trial is testing

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00408655
What this trial is testing

Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerRecurrent Endometrial Carcinoma+9 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Early research (Phase 1)Looking for participantsNCT06769425
What this trial is testing

HS-10502 Combination Treatment in Patients With Advanced Solid Tumors

Who this might be right for
Recurrent Ovarian CancerHER2-negativeAdvanced Breast Cancer+3 more
Jiangsu Hansoh Pharmaceutical Co., Ltd. 157
Post-approval studies (Phase 4)Not Yet RecruitingNCT07075250
What this trial is testing

Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study

Who this might be right for
Platinum-resistant Ovarian Cancer (PROC)
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01175343
What this trial is testing

RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+3 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00006230
What this trial is testing

Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC 51
Large-scale testing (Phase 3)Study completedNCT00113607
What this trial is testing

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 672
Testing effectiveness (Phase 2)Looking for participantsNCT06873555
What this trial is testing

DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Solid TumorsOvarian CancerSmall Cell Lung Cancer
Heronova Pharmaceuticals 60
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00562640
What this trial is testing

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286687
What this trial is testing

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

Who this might be right for
Advanced Malignant NeoplasmATM Gene MutationBRCA1 Gene Mutation+5 more
M.D. Anderson Cancer Center 150
Early research (Phase 1)Looking for participantsNCT07444814
What this trial is testing

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerOvarian Cancer Metastatic+4 more
Whitehawk Therapeutics, Inc. 226
Testing effectiveness (Phase 2)Study completedNCT01079832
What this trial is testing

Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

Who this might be right for
Fallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Next Page